<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220713055455N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-11-03</date_registration>
      <primary_sponsor>Semnan University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of whole body vibration before and after eccentric exercise on functional markers of delayed onset muscle soreness</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of whole body vibration before and after eccentric exercise on functional markers of delayed onset muscle soreness</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-10-02</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>48</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/65108</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: -, Randomization description: In this research, available sampling method and random grouping based on coding method will be used. The samples are coded with two-digit numbers using a random number table and randomly selected from a point of the table until the number of samples is 48, Blinding description: In this research, 48 male and female sitting volleyball athletes are studied. The initial sampling will be voluntary, but in the next stage, subjects will be randomly (systematically) selected from among those who are eligible and registered.</study_design>
      <phase>N/A</phase>
      <hc_freetext>delayed onset muscle soreness.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: Seated volleyball athletes (16 people) after warming up and stretching for 5 minutes will perform 50 outward contractions with an intensity of 85% of 1RM and then undergo vibration therapy for one minute with a frequency of 40 Hz - with peak amplitude. They will be placed up to the top of 2 mm. Intervention 2: Intervention group 2: Seated volleyball athletes (16 people) before warming up and stretching for 5 minutes will perform 50 outward contractions with an intensity of 85% of 1RM and then undergo vibration therapy for one minute with a frequency of 40 Hz - with peak amplitude. They will be placed up to the top of 2 mm. Intervention 3: Control group: The control group (16 people) - sitting volleyball athletes (16 people) will perform warm-up and stretching exercises for 5 minutes, 50 outward contractions with an intensity of 85% of 1RM, and undergo vibration therapy before and after training. are not placed.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is اطلاعات بیشتری وجود ندارد</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nasrin Irvani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University Blvd., End of University 17, Dead end 16, No. 19</address>
        <city>neyshabour</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>93197-43875</zip>
        <telephone>+98 51 4261 0946</telephone>
        <email>n.irvani737@gmail.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nasrin Irvani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University Blvd., End of University 17, Dead end 16, No. 19</address>
        <city>neyshabour</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>93197-43875</zip>
        <telephone>+98 51 4261 0946</telephone>
        <email>n.irvani737@gmail.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Male and female seated volleyball athletes</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>25 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Using nutritional interventions (consuming high-fat food during the implementation of the protocol)
Use of interfering medicinal substances (use of painkillers and intramuscular injections) before the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: Seated volleyball athletes (16 people) after warming up and stretching for 5 minutes will perform 50 outward contractions with an intensity of 85% of 1RM and then undergo vibration therapy for one minute with a frequency of 40 Hz - with peak amplitude. They will be placed up to the top of 2 mm.</i_keyword>
      <i_keyword>Intervention group 2: Seated volleyball athletes (16 people) before warming up and stretching for 5 minutes will perform 50 outward contractions with an intensity of 85% of 1RM and then undergo vibration therapy for one minute with a frequency of 40 Hz - with peak amplitude. They will be placed up to the top of 2 mm.</i_keyword>
      <i_keyword>Control group: The control group (16 people) - sitting volleyball athletes (16 people) will perform warm-up and stretching exercises for 5 minutes, 50 outward contractions with an intensity of 85% of 1RM, and undergo vibration therapy before and after training. are not placed</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Isometric strength. Timepoint: All measurements will be done before, immediately after, 24, 48 and 72 hours and one week and two weeks after the implementation of the protocol. Method of measurement: To measure isometric (static) strength, the examinee holds the dynamometer in one hand so that the hand is in line with the arm and hangs next to the thigh. Without moving his hand, he displays his maximum power by pressing the dynamometer. This movement should be repeated 2 times.</prim_outcome>
      <prim_outcome>Range of motion of the non-dominant elbow. Timepoint: All measurements will be done before, immediately after, 24, 48 and 72 hours and one week and two weeks after the implementation of the protocol. Method of measurement: The goniometer will be used to measure the range of motion. To measure the range of motion, the fixed arm of the goniometer will be placed parallel to the acromion-radial line and the movable arm of the goniometer will be placed on the radial-ulnar line in anatomical position.</prim_outcome>
      <prim_outcome>Circumference of the non-dominant arm. Timepoint: All measurements will be done before, immediately after, 24, 48 and 72 hours and one week and two weeks after the implementation of the protocol. Method of measurement: A tape measure is used to measure the circumference of the arm. To measure the circumference of the arm, first, the middle point of the acromion-radial line is determined, then the person places his hand in a hanging position next to the body, and the circumference of the arm is at the mentioned point. It will be measured perpendicular to the length of the arm.</prim_outcome>
      <prim_outcome>Muscle contusion(visual analogue scale). Timepoint: All measurements will be done before, immediately after, 24, 48 and 72 hours and one week and two weeks after the implementation of the protocol. Method of measurement: In order to measure muscle contusion, a visual perception chart will be used. This chart contains 10 grades, zero indicates the absence of pain, and grade 5 indicates pain that is caused by movement and causes little restriction. Grade 10 also indicates pain that may prevent any movement.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Semnan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-07-06</approval_date>
        <contact_name>Ethics Committee of Semnan University of Medical Sciences</contact_name>
        <contact_address>KM 5 of Damghan road Semnan Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
